Battery Partners IX’s Champions Oncology CSBR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$22.4M Hold
2,421,673
100% 1
2020
Q2
$23.2M Hold
2,421,673
100% 1
2020
Q1
$17.9M Buy
2,421,673
+409,791
+20% +$2.86M 100% 1
2019
Q4
$16.8M Hold
2,011,882
17.68% 3
2019
Q3
$11.4M Hold
2,011,882
6.58% 4
2019
Q2
$15.8M Hold
2,011,882
4.14% 4
2019
Q1
$19.7M Buy
2,011,882
+58,333
+3% +$581K 5.21% 3
2018
Q4
$15.3M Hold
1,953,549
5.57% 3
2018
Q3
$34.1M Hold
1,953,549
11.01% 3
2018
Q2
$12.4M Hold
1,953,549
3.03% 3
2018
Q1
$7.11M Hold
1,953,549
7.42% 2
2017
Q4
$7.58M Hold
1,953,549
7.58% 3
2017
Q3
$7.17M Hold
1,953,549
9.12% 3
2017
Q2
$5.02M Hold
1,953,549
4.84% 4
2017
Q1
$6.19M Hold
1,953,549
4.57% 4
2016
Q4
$4.94M Hold
1,953,549
3.03% 4
2016
Q3
$3.28M Hold
1,953,549
1.55% 4
2016
Q2
$4.2M Hold
1,953,549
2.23% 4
2016
Q1
$7.11M Hold
1,953,549
3.34% 4
2015
Q4
$6.97M Hold
1,953,549
2.66% 4
2015
Q3
$10.5M Buy
+1,953,549
New +$12.8M 3.89% 4

Other funds holding CSBR

Battery Partners IX's CSBR Position: Q3 2020 in Review

Battery Partners IX held its Champions Oncology (CSBR) position steady in Q3 2020 at 2,421,673 shares worth $22.4M. The position accounts for 100% of the portfolio, ranked #1.

Battery Partners IX first reported a position in CSBR in Q3 2015 and has held it in 21 quarters since. The position peaked at $34.1M in Q3 2018. 46 funds tracked by Wall St. Rank hold CSBR as of Q3 2020.

  • Battery Partners IX held 2,421,673 shares of Champions Oncology worth $22.4M as of Q3 2020.
  • Battery Partners IX left its Champions Oncology share count unchanged in Q3 2020.
  • Champions Oncology made up 100% of Battery Partners IX's portfolio in Q3 2020, its #1 holding.
  • Battery Partners IX first reported a position in Champions Oncology in Q3 2015 and has held it in 21 quarters since.
  • Battery Partners IX's Champions Oncology position peaked at $34.1M in Q3 2018.
  • 46 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2020.

Based on Battery Partners IX's 13F filing for Q3 2020, filed 16 Nov 2020.